Salomon & Ludwin’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.3K Buy
507
+117
+30% +$5.83K ﹤0.01% 867
2026
Q2
$18.8K Buy
390
+125
+47% +$6.42K ﹤0.01% 1198
2026
Q1
$13.9K Sell
265
-80
-23% -$5.19K ﹤0.01% 1334
2025
Q4
$21.6K Buy
345
+178
+107% +$10.9K ﹤0.01% 842
2025
Q3
$10.7K Buy
+167
New +$11.6K ﹤0.01% 1256

Other funds holding PBH

Salomon & Ludwin's PBH Position: Q3 2026 in Review

Salomon & Ludwin increased its Prestige Consumer Healthcare (PBH) stake by 30% in Q3 2026, buying an estimated $5.83K and bringing the position to 507 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #867.

Salomon & Ludwin first reported a position in PBH in Q3 2025 and has held it in 5 quarters since. 136 funds tracked by Wall St. Rank hold PBH as of Q3 2026.

  • Salomon & Ludwin held 507 shares of Prestige Consumer Healthcare worth $23.3K as of Q3 2026.
  • Salomon & Ludwin bought 117 Prestige Consumer Healthcare shares in Q3 2026, an estimated $5.83K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #867 holding.
  • Salomon & Ludwin first reported a position in Prestige Consumer Healthcare in Q3 2025 and has held it in 5 quarters since.
  • 136 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.